ARTICLE | Company News
Epimmune names new president, CEO
January 18, 2001 8:00 AM UTC
EPMN, a developer of cellular immunity vaccines for cancer and infectious diseases, hired Emile Loria as president, CEO and a director. Prior, he was president and CEO of vaccine company Biovector The...